Lantheus Alpha Therapy, LLC - 22 Jan 2024 Form 3 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role: 10%+ Owner
Signature: /s/ Daniel Niedzwiecki, Chief Administrative Officer and General Counsel, Lantheus
Issuer symbol: CATX
Transactions as of: 22 Jan 2024
Net transactions value: $0
Form type: 3
Filing time: 01 Feb 2024, 07:56:36 UTC
Next filing: 08 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CATX	Common Stock						56,342,355	22 Jan 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents securities directly held by Lantheus Alpha Therapy, LLC ("Lantheus"), a wholly owned direct subsidiary of Lantheus Holdings, Inc. ("Lantheus Holdings"). Under SEC rules and regulations, Lantheus Holdings may be deemed to have indirect beneficial ownership of the shares held by Lantheus, which has direct beneficial ownership.